Authors
Loading...
Preclinical study demonstrates that WASp activation boosts phagocytosis in tumor-associated macrophages, enhancing ibrutinib's effectiveness against brain tumors.
Cheng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: